FDA Counterdetailing Influenza Treatments Relenza and Tamiflu
FDA is taking action to curb inappropriate prescribing of Glaxo Wellcome's Relenza and Roche's Tamiflu.
FDA is taking action to curb inappropriate prescribing of Glaxo Wellcome's Relenza and Roche's Tamiflu.